10X Genomics, Inc. (TXG)
93.50
+4.74
(+5.34%)
USD |
NASDAQ |
Oct 02, 16:00
94.00
+0.50
(+0.53%)
After-Hours: 20:00
10X Genomics Max Drawdown (5Y) : 96.47% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 96.47% |
| August 31, 2026 | 96.47% |
| July 31, 2026 | 96.47% |
| June 30, 2026 | 96.47% |
| May 31, 2026 | 96.47% |
| April 30, 2026 | 96.47% |
| March 31, 2026 | 96.47% |
| February 28, 2026 | 96.47% |
| January 31, 2026 | 96.47% |
| December 31, 2025 | 96.47% |
| November 30, 2025 | 96.47% |
| October 31, 2025 | 96.47% |
| September 30, 2025 | 96.47% |
| August 31, 2025 | 96.47% |
| July 31, 2025 | 96.47% |
| June 30, 2025 | 96.47% |
| May 31, 2025 | 96.47% |
| April 30, 2025 | 96.47% |
| March 31, 2025 | 95.69% |
| February 28, 2025 | 94.72% |
| January 31, 2025 | 93.49% |
| December 31, 2024 | 93.49% |
| November 30, 2024 | 93.49% |
| October 31, 2024 | 92.66% |
| September 30, 2024 | 92.24% |
| Date | Value |
|---|---|
| August 31, 2024 | 92.24% |
| July 31, 2024 | 92.24% |
| June 30, 2024 | 90.39% |
| May 31, 2024 | 89.07% |
| April 30, 2024 | 87.94% |
| March 31, 2024 | 87.94% |
| February 29, 2024 | 87.94% |
| January 31, 2024 | 87.94% |
| December 31, 2023 | 87.94% |
| November 30, 2023 | 87.94% |
| October 31, 2023 | 87.94% |
| September 30, 2023 | 87.94% |
| August 31, 2023 | 87.94% |
| July 31, 2023 | 87.94% |
| June 30, 2023 | 87.94% |
| May 31, 2023 | 87.94% |
| April 30, 2023 | 87.94% |
| March 31, 2023 | 87.94% |
| February 28, 2023 | 87.94% |
| January 31, 2023 | 87.94% |
| December 31, 2022 | 87.94% |
| November 30, 2022 | 87.94% |
| October 31, 2022 | 87.94% |
| September 30, 2022 | 85.93% |
| August 31, 2022 | 83.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Twist Bioscience Corp. | 94.48% |
| Tempus AI, Inc. | -- |
| Personalis, Inc. | 98.18% |
| Alamar Biosciences, Inc. (California) | -- |
| Beam Therapeutics, Inc. | 89.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -32.81 |
| Beta (5Y) | 1.992 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 69.68% |
| Historical Sharpe Ratio (5Y) | -0.1849 |
| Historical Sortino (5Y) | -0.39 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.63% |